Market Tracker

06/23 3:02pm ET
66.11
BATS BZX Real-Time Price
As of 3:02pm ET
 +0.09 / +0.14%
Today’s Change
55.10
Today|||52-Week Range
66.80
+12.30%
Year-to-Date
Pharma Stock Roundup: NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod
8:18am / Zacks.com - Paid Partner Content
Bristol-Myers Opdivo Positive in Phase II Study CheckMate-205
Jun 19 / Zacks.com - Paid Partner Content
Stocks to Fight Cancer: Why Immunotherapy Is a Gamechanger
Jun 22 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: J&J, Lilly Present Data, Merck Keytruda Study Enrolment Paused
Jun 16 / Zacks.com - Paid Partner Content
Merck's Powerful Rally Is Coming So Back Up the Truck
Jun 22 / TheStreet.com - Paid Partner Content
CEOs to Trump: You're failing
Jun 15 / CNNMoney.com
Why You Should Add Novo Nordisk Stock to Your Portfolio
Jun 22 / Zacks.com - Paid Partner Content
Gilead (GILD) Submits NDA for HIV Combination Therapy Regimen
Jun 13 / Zacks.com - Paid Partner Content
Glaxo's (GSK) Shingles Candidate Phase III Data Positive
Jun 22 / Zacks.com - Paid Partner Content
J&J's Invokana Lowers Heart Issues, Raises Amputation Risk
Jun 13 / Zacks.com - Paid Partner Content
Merck's Keytruda on a Roll: Can it Retain the Momentum?
Jun 22 / Zacks.com - Paid Partner Content
Merck Stalls Enrolment in Two Myeloma Studies of Keytruda
Jun 13 / Zacks.com - Paid Partner Content
Ligand Gets Milestone Payment on Partner Drug FDA Approval
Jun 21 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Facebook, Wal-Mart, Merck, Kellogg and PACCAR
Jun 13 / Zacks.com - Paid Partner Content
VBI Vaccines Just Took a Major Step Forward in Its HBV Program
Jun 21 / GuruFocus News - Paid Partner Content
New Research Reports for Facebook, Wal-Mart & Merck
Jun 12 / Zacks.com - Paid Partner Content
Dems Roast Trump for Leaving Medicare Out of Drug Price Order
Jun 21 / TheStreet.com - Paid Partner Content
Merck's Diabetes Drug Meets Primary Endpoint in Key Studies
Jun 12 / Zacks.com - Paid Partner Content
Novo Nordisk's Victoza Gets FDA Panel Nod for Label Expansion
Jun 21 / Zacks.com - Paid Partner Content
Inovio's HPV Immunotherapy Moves to Phase III, Stock Rises
Jun 09 / Zacks.com - Paid Partner Content
Small Cancer Biotech Space in Focus, 3 Stocks Up 100% & More
Jun 21 / Zacks.com - Paid Partner Content
Four things to watch at the Asco cancer meeting
May 30 / FT.com - Paid Partner Content